Schedule 13G ownership disclosure

Contineum Therapeutics Inc

Security class unavailable · CUSIP: 21217B100

Event date: 2024-04-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-24-002557
Form type
SC 13G
Filer
Contineum Therapeutics, Inc.
CIK
CIK 1855175
Filed
Apr 15, 2024
Reporting period
Apr 05, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub